Phenixfin Accounts Payable vs Deferred Long Term Liab Analysis

PFX Stock

USD 46.75 0.47 1.02%

Phenixfin financial indicator trend analysis is much more than just breaking down Phenixfin prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Phenixfin is a good investment. Please check the relationship between Phenixfin Accounts Payable and its Deferred Long Term Liab accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phenixfin. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy Phenixfin Stock please use our How to Invest in Phenixfin guide.

Accounts Payable vs Deferred Long Term Liab

Accounts Payable vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Phenixfin Accounts Payable account and Deferred Long Term Liab. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Phenixfin's Accounts Payable and Deferred Long Term Liab is -0.11. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Phenixfin, assuming nothing else is changed. The correlation between historical values of Phenixfin's Accounts Payable and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Phenixfin are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Accounts Payable i.e., Phenixfin's Accounts Payable and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.11

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Phenixfin obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Phenixfin are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Phenixfin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Phenixfin current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phenixfin. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy Phenixfin Stock please use our How to Invest in Phenixfin guide.At this time, Phenixfin's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 4.60 in 2024, whereas Selling General Administrative is likely to drop slightly above 3.3 M in 2024.

Phenixfin fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Net Debt	Cash	Non Current Assets Total	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Total Liab	Total Current Assets	Intangible Assets	Total Stockholder Equity	Current Deferred Revenue	Retained Earnings	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Common Stock	Other Current Liab	Property Plant And Equipment Net	Accounts Payable
Total Assets		1.0	0.65	1.0	0.89	0.17	1.0	1.0	1.0	1.0	0.94	0.97	-0.08	-0.25	0.46	0.16	0.16	-0.16	-0.17	-0.08	-0.27	-0.63	-0.07	0.1	0.39	-0.14
Short Long Term Debt Total	1.0		0.64	1.0	0.88	0.14	1.0	1.0	1.0	1.0	0.95	0.97	-0.11	-0.26	0.46	0.14	0.15	-0.16	-0.2	-0.11	-0.3	-0.63	-0.1	0.11	0.37	-0.15
Total Current Liabilities	0.65	0.64		0.64	0.58	0.42	0.63	0.63	0.63	0.64	0.65	0.65	0.3	-0.27	0.23	0.21	0.32	-0.06	0.43	0.21	0.1	-0.24	0.21	-0.04	0.47	0.65
Net Debt	1.0	1.0	0.64		0.88	0.14	1.0	1.0	1.0	1.0	0.95	0.97	-0.11	-0.26	0.46	0.14	0.14	-0.17	-0.2	-0.11	-0.3	-0.63	-0.1	0.11	0.38	-0.15
Cash	0.89	0.88	0.58	0.88		0.24	0.88	0.88	0.89	0.88	0.88	0.9	-0.02	-0.36	0.31	0.22	0.36	0.32	-0.16	-0.09	-0.08	-0.58	0.12	-0.18	0.12	-0.17
Non Current Assets Total	0.17	0.14	0.42	0.14	0.24		0.12	0.11	0.12	0.14	0.01	0.2	0.95	0.36	0.09	0.62	0.48	0.27	0.77	0.87	0.88	-0.27	0.85	-0.53	0.57	0.37
Good Will	1.0	1.0	0.63	1.0	0.88	0.12		1.0	1.0	1.0	0.95	0.97	-0.13	-0.28	0.47	0.13	0.14	-0.17	-0.21	-0.13	-0.32	-0.62	-0.12	0.12	0.37	-0.16
Common Stock Total Equity	1.0	1.0	0.63	1.0	0.88	0.11	1.0		1.0	1.0	0.95	0.97	-0.13	-0.27	0.46	0.13	0.13	-0.17	-0.21	-0.13	-0.32	-0.62	-0.12	0.13	0.36	-0.16
Common Stock Shares Outstanding	1.0	1.0	0.63	1.0	0.89	0.12	1.0	1.0		1.0	0.95	0.97	-0.13	-0.28	0.45	0.13	0.14	-0.16	-0.21	-0.13	-0.31	-0.61	-0.11	0.12	0.36	-0.16
Total Liab	1.0	1.0	0.64	1.0	0.88	0.14	1.0	1.0	1.0		0.95	0.97	-0.1	-0.26	0.46	0.14	0.15	-0.16	-0.19	-0.1	-0.29	-0.63	-0.09	0.11	0.38	-0.15
Total Current Assets	0.94	0.95	0.65	0.95	0.88	0.01	0.95	0.95	0.95	0.95		0.94	-0.22	-0.47	0.36	-0.04	0.22	-0.07	-0.28	-0.25	-0.37	-0.5	-0.16	0.13	0.26	-0.12
Intangible Assets	0.97	0.97	0.65	0.97	0.9	0.2	0.97	0.97	0.97	0.97	0.94		-0.04	-0.35	0.48	0.19	0.3	-0.08	-0.18	-0.08	-0.23	-0.68	-0.01	0.04	0.41	-0.14
Total Stockholder Equity	-0.08	-0.11	0.3	-0.11	-0.02	0.95	-0.13	-0.13	-0.13	-0.1	-0.22	-0.04		0.4	0.04	0.59	0.45	0.21	0.85	0.93	0.9	-0.16	0.83	-0.47	0.59	0.44
Current Deferred Revenue	-0.25	-0.26	-0.27	-0.26	-0.36	0.36	-0.28	-0.27	-0.28	-0.26	-0.47	-0.35	0.4		-0.12	0.09	-0.56	-0.19	0.46	0.55	0.41	0.1	0.3	-0.15	0.1	0.06
Retained Earnings	0.46	0.46	0.23	0.46	0.31	0.09	0.47	0.46	0.45	0.46	0.36	0.48	0.04	-0.12		0.26	0.25	-0.29	-0.12	0.06	-0.2	-0.82	0.0	0.12	0.59	-0.19
Non Currrent Assets Other	0.16	0.14	0.21	0.14	0.22	0.62	0.13	0.13	0.13	0.14	-0.04	0.19	0.59	0.09	0.26		0.43	0.2	0.45	0.55	0.47	-0.4	0.38	-0.15	0.4	0.08
Other Assets	0.16	0.15	0.32	0.14	0.36	0.48	0.14	0.13	0.14	0.15	0.22	0.3	0.45	-0.56	0.25	0.43		0.48	0.12	0.23	0.42	-0.38	0.54	-0.45	0.35	0.08
Cash And Short Term Investments	-0.16	-0.16	-0.06	-0.17	0.32	0.27	-0.17	-0.17	-0.16	-0.16	-0.07	-0.08	0.21	-0.19	-0.29	0.2	0.48		0.09	0.07	0.47	0.05	0.49	-0.62	-0.47	-0.02
Net Receivables	-0.17	-0.2	0.43	-0.2	-0.16	0.77	-0.21	-0.21	-0.21	-0.19	-0.28	-0.18	0.85	0.46	-0.12	0.45	0.12	0.09		0.82	0.74	0.13	0.61	-0.26	0.42	0.77
Short Term Investments	-0.08	-0.11	0.21	-0.11	-0.09	0.87	-0.13	-0.13	-0.13	-0.1	-0.25	-0.08	0.93	0.55	0.06	0.55	0.23	0.07	0.82		0.8	-0.19	0.66	-0.23	0.57	0.38
Non Current Liabilities Total	-0.27	-0.3	0.1	-0.3	-0.08	0.88	-0.32	-0.32	-0.31	-0.29	-0.37	-0.23	0.9	0.41	-0.2	0.47	0.42	0.47	0.74	0.8		0.07	0.89	-0.65	0.24	0.38
Other Stockholder Equity	-0.63	-0.63	-0.24	-0.63	-0.58	-0.27	-0.62	-0.62	-0.61	-0.63	-0.5	-0.68	-0.16	0.1	-0.82	-0.4	-0.38	0.05	0.13	-0.19	0.07		-0.14	0.03	-0.54	0.35
Common Stock	-0.07	-0.1	0.21	-0.1	0.12	0.85	-0.12	-0.12	-0.11	-0.09	-0.16	-0.01	0.83	0.3	0.0	0.38	0.54	0.49	0.61	0.66	0.89	-0.14		-0.87	0.33	0.3
Other Current Liab	0.1	0.11	-0.04	0.11	-0.18	-0.53	0.12	0.13	0.12	0.11	0.13	0.04	-0.47	-0.15	0.12	-0.15	-0.45	-0.62	-0.26	-0.23	-0.65	0.03	-0.87		0.04	-0.1
Property Plant And Equipment Net	0.39	0.37	0.47	0.38	0.12	0.57	0.37	0.36	0.36	0.38	0.26	0.41	0.59	0.1	0.59	0.4	0.35	-0.47	0.42	0.57	0.24	-0.54	0.33	0.04		0.2
Accounts Payable	-0.14	-0.15	0.65	-0.15	-0.17	0.37	-0.16	-0.16	-0.16	-0.15	-0.12	-0.14	0.44	0.06	-0.19	0.08	0.08	-0.02	0.77	0.38	0.38	0.35	0.3	-0.1	0.2

Click cells to compare fundamentals

Phenixfin Account Relationship Matchups

Phenixfin fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	306.1M	225.1M	218.9M	239.7M	215.7M	204.9M
Short Long Term Debt Total	151.0M	78.0M	78.5M	84.5M	76.1M	72.3M
Total Current Liabilities	4.5M	3.4M	19.2M	(156.4K)	(140.7K)	(133.7K)
Net Debt	94.4M	8.6M	55.8M	78.5M	70.7M	67.2M
Cash	56.5M	69.4M	22.8M	6.0M	5.4M	5.1M
Non Current Assets Total	248.8M	153.0M	194.2M	228.0M	205.2M	194.9M
Liabilities And Stockholders Equity	306.1M	225.1M	218.9M	239.7M	215.7M	204.9M
Total Liab	155.5M	81.4M	98.0M	93.0M	83.7M	79.5M
Total Current Assets	57.3M	72.1M	24.7M	11.7M	10.5M	10.0M
Accumulated Other Comprehensive Income	150.6M	143.7M	120.8M	146.7M	168.7M	177.1M
Total Stockholder Equity	150.6M	143.7M	120.8M	146.7M	132.0M	125.4M
Current Deferred Revenue	(76.9M)	(77.4M)	(78.0M)	421.7M	379.5M	398.5M
Retained Earnings	(521.8M)	(545.2M)	(554.6M)	(548.1M)	(493.3M)	(468.6M)
Non Currrent Assets Other	(304.0M)	788.2K	729.5K	(226.9M)	(204.2M)	(194.0M)
Other Assets	2.1M	1.4M	(1.4M)	(6.9B)	(6.3B)	(5.9B)
Cash And Short Term Investments	56.5M	69.4M	22.8M	6.0M	6.9M	6.5M
Net Receivables	743.6K	2.6M	1.4M	5.5M	5.0M	5.9M
Non Current Liabilities Total	151.0M	78.0M	78.9M	85.2M	76.7M	72.9M
Other Stockholder Equity	672.4M	688.9M	675.4M	694.8M	799.0M	623.2M
Common Stock	2.7K	2.5K	2.1K	2.1K	1.9K	1.8K
Other Current Liab	(76.1M)	1.9M	578.0K	(7.2M)	(8.3M)	(8.7M)
Accounts Payable	2.1M	1.4M	18.6M	7.2M	6.5M	8.5M
Short Term Debt	74.0M	77.4M	78.0M	84.3M	75.8M	72.0M
Other Liab	103.6K	10.5K	34.0	327.9K	295.1K	240.8K
Net Tangible Assets	216.4M	150.6M	143.7M	120.8M	108.8M	188.4M
Net Invested Capital	301.6M	221.1M	198.8M	231.0M	207.9M	354.2M
Long Term Investments	246.7M	151.6M	193.0M	226.5M	203.8M	309.4M
Capital Stock	2.7K	2.5K	2.1K	2.1K	1.9K	1.8K
Other Current Assets	0.0	292.0K	1.4M	639.7K	735.6K	772.4K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Phenixfin Stock Analysis

When running Phenixfin's price analysis, check to measure Phenixfin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phenixfin is operating at the current time. Most of Phenixfin's value examination focuses on studying past and present price action to predict the probability of Phenixfin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phenixfin's price. Additionally, you may evaluate how the addition of Phenixfin to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Phenixfin Accounts Payable vs Deferred Long Term Liab Analysis

Accounts Payable vs Deferred Long Term Liab

Accounts Payable vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Accounts Payable

Deferred Long Term Liab

Phenixfin fundamental ratios Correlations

Phenixfin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Phenixfin fundamental ratios Accounts

Also Currently Popular

Additional Tools for Phenixfin Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Long Term Debt Total	+ 1.0	Total Assets
Net Debt	+ 1.0	Total Assets
Good Will	+ 1.0	Total Assets
Common Stock Total Equity	+ 1.0	Total Assets
Common Stock Shares Outstanding	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets

Other Current Liab	- 0.87	Common Stock
Other Stockholder Equity	- 0.82	Retained Earnings
Other Stockholder Equity	- 0.68	Intangible Assets
Other Current Liab	- 0.65	Non Current Liabilities Total
Other Stockholder Equity	- 0.63	Total Liab
Other Stockholder Equity	- 0.63	Net Debt